B. Fletcher

发表

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

M. Ellis, P. Sorensen, M. Baker, 2018, Cancer research.

TEM8 specific T cells target the tumor cells and tumor-associated vasculature in triple negative breast cancer

A. Pignata, B. St. Croix, N. Ahmed, 2014, Journal of Immunotherapy for Cancer.

Tumor endothelial marker 8 expression in triple-negative breast cancer.

S. Grobmyer, E. Copeland, S. Al-Quran, 2011, Anticancer research.

Vasculature of Colorectal Carcinomas in Mice Targeting Tumor Endothelial Marker 8 in the Tumor

B. Fletcher, S. Fernando, 2009 .

Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

B. Fletcher, S. Fernando, 2009, Cancer research.

Targeting tumor endothelial marker 8 in the tumor vasculature of colorectal carcinomas in mice.

B. Fletcher, S. Fernando, 2009 .

The promise of nanotechnology for solving clinical problems in breast cancer

Scott C. Brown, B. Moudgil, S. Grobmyer, 2011, Journal of surgical oncology.

Advancements in Non Viral Gene Therapy for Hemophilia

B. Fletcher, 2012 .

Sustained FVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon.

C. Mah, B. Fletcher, Li Liu, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Development and validation of an approach to produce large‐scale quantities of CpG‐methylated plasmid DNA

B. Fletcher, 2007, Microbial biotechnology.

Modulation of epithelial morphology, monolayer permeability, and cell migration by growth arrest specific 3/peripheral myelin protein 22.

L. Notterpek, K. Roux, B. Fletcher, 2005, Molecular biology of the cell.

Impaired proteasome activity and accumulation of ubiquitinated substrates in a hereditary neuropathy model

L. Notterpek, A. Fenstermaker, B. Fletcher, 2005, Journal of neurochemistry.

Sleeping Beauty‐mediated eNOS gene therapy attenuates monocrotaline‐induced pulmonary hypertension in rats

G. Visner, Hanzhong Liu, B. Fletcher, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

784. Sleeping Beauty-Mediated eNOS Gene Therapy Attenuates Monocrotaline-Induced Pulmonary Hypertension

G. Visner, Hanzhong Liu, B. Fletcher, 2006 .

Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.

C. Hu, V. Baker, G. Núñez, 1998, Gynecologic oncology.

Dual targeting of the tumor and its associated vasculature using a single bispecific chimeric antigen receptor molecule

A. Pignata, B. St. Croix, N. Ahmed, 2014, Journal of Immunotherapy for Cancer.

Novel action of indoleamine 2,3-dioxygenase attenuating acute lung allograft injury.

G. Visner, Hanzhong Liu, B. Fletcher, 2006, American journal of respiratory and critical care medicine.

Glucose deprivation enhances targeting of GLUT1 to lipid rafts in 3T3-L1 adipocytes.

P. Laipis, Yu-Ping Xiao, B. Fletcher, 2004, American journal of physiology. Endocrinology and metabolism.

Endothelial targeting of the Sleeping Beauty transposon within lung.

L. Notterpek, Vijay Antharam, B. Fletcher, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer.

Matthew H. Wilson, B. Fletcher, D. Galvan, 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

Potent Anti-tumor Effects of an Active Site Mutant of Human Manganese-Superoxide Dismutase

D. Silverman, J. Melendez, H. Nick, 2004, Journal of Biological Chemistry.

Modulation of epithelial morphology , monolayer permeability and cell migration by gas 3 / PMP 22

L. Notterpek, K. Roux, B. Fletcher, 2004 .

Indoleamine 2,3-dioxygenase attenuates inhibitor development in gene-therapy-treated hemophilia A mice

C. Mah, B. Fletcher, H. Liu, 2009, Gene Therapy.

Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

M. Kilberg, B. Fletcher, A. Aslanian, 2001, The Biochemical journal.

Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates

Boris Jerchow, Janka Matrai, Zoltán Ivics, 2009, Nature Genetics.

Transposon-based RNAi delivery system for generating knockdown cell lines.

L. Notterpek, Lucia Notterpek, B. Fletcher, 2004, Biochemical and biophysical research communications.

Sleeping Beauty Transposon-Mediated Nonviral Gene Therapy

B. Fletcher, S. Fernando, 2012, BioDrugs.

Sleeping Beauty‐based gene therapy with indoleamine 2,3‐dioxygenase inhibits lung allograft fibrosis

G. Visner, Hanzhong Liu, B. Fletcher, 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

The WD-repeat protein GRWD1: potential roles in myeloid differentiation and ribosome biogenesis.

L. Notterpek, D. G. Pestov, B. Fletcher, 2005, Genomics.

Hyperactive transposase mutants of the Sleeping Beauty transposon.

B. Fletcher, Arnold D Heggestad, Li Liu, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: Implications for neuropathy severity

K. Roux, L. Notterpek, B. Fletcher, 2005, Journal of neuroscience research.

BCL-2 MEDIATED MODULATION OF VASCULARIZATION IN PROSTATE CANCER XENOGRAFTS

Wengang Cao, S. Goodison, S. Anai, 2009 .

Bcl‐2 mediated modulation of vascularization in prostate cancer xenografts

Wengang Cao, S. Goodison, S. Anai, 2009, The Prostate.

Glycogen phosphorylase is activated in response to glucose deprivation but is not responsible for enhanced glucose transport activity in 3T3-L1 adipocytes.

W. Pawlina, P. Laipis, B. Fletcher, 2002, Biochimica et biophysica acta.

Transcriptional induction of prostaglandin G/H synthase-2 by basic fibroblast growth factor.

M. Hurley, H. Herschman, H. Kawaguchi, 1995, The Journal of clinical investigation.

v-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element

H. Herschman, Weilin Xie, W. Xie, 1994, Molecular and cellular biology.

TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

B. Varnum, H. Herschman, R. Lim, 1991, The Journal of biological chemistry.

Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase.

H. Herschman, D. Perrin, B. Fletcher, 1992, The Journal of biological chemistry.

TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.

M. Ellis, P. Sorensen, M. Baker, 2018, Cancer research.